Korea

Bridge Biotherapeutics Presented the Preclinical Data of BBT-207 at the AACR Annual Meeting 2022

* The preclinical data supports the clinical development of BBT-207 for EGFR mutant NSCLC patients harboring C797S double mutations, as well as for those who are treatment-naïve * The company plans to submit an IND application to the US FDA in 2022 and looks forward to entering the Phase 1 st...

2022-04-13 06:00 768

/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued11-Apr-2022 over PR Newswire. ...

2022-04-12 15:34 1360

PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022

DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), aclinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA ...

2022-04-11 20:00 593

Samyang Foods sponsors BTS PERMISSION TO DANCE ON STAGE - LAS VEGAS

- Part of global promotion campaign of K-spicy to commemorate the 10th anniversary of the launching Buldak SEOUL, South Korea, April 8, 2022 /PRNewswire/ -- Samyang Foods announced on April 8 that it will participate as the main sponsor of BTS PERMISSION TO DANCE ON STAGE –LAS VEGAS, commemorati...

2022-04-09 00:00 3370

OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

* Identified knockdown of target genes for the NASH treatment candidate * Reduction of ALT and AST liver marker levels observed in monkey models * Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, South Korea, April 8, 2022 /PRNewswire/ -- OliX ...

2022-04-08 20:00 2803

LG Energy Solution Releases Preliminary Earnings for First Quarter 2022

SEOUL, South Korea, April 7, 2022 /PRNewswire/ -- LG Energy Solution (LGES; KRX: 373220) today announced its preliminary earnings results for the first quarter of 2022. LGES reported revenues of KRW 4.34 trillion, a decrease of 2.2% compared to the previous quarter. LG Energy Solution's first q...

2022-04-07 15:55 1609

LG Display Demonstrates OLED.EX's Evolutionary Experience at 2022 OLED Korea Conference

SEOUL, South Korea, April 6, 2022 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today thatLee Hyeon-woo, Senior Vice President and Head of Life Display Business Group at LG Display, gave a keynote speech under the theme of 'OLED, The Evolutionary Exp...

2022-04-07 12:16 1648

HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets

CHENGDU, China, April 6, 2022 /PRNewswire/ -- HitGen Inc. ("HitGen"), a Shanghai Stock Exchange STAR-listed company (ticker code 688222.SH), today announced that the company has successfully completed the multiple-target drug discovery research projects with UPPTHERA, a Korean pharmaceutical comp...

2022-04-06 22:30 1919

New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities

* Lunit to present two abstracts about its AI-biomarker for immunotherapy, Lunit SCOPE IO * Lunit will deliver an oral presentation on its breakthrough study supporting the effectiveness of Lunit SCOPE IO as a prognostic biomarker for endometrial cancer SEOUL, South Korea, April 6, 2022 /PRNe...

2022-04-06 21:44 1695

LG Display's Gaming OLED Video Series Hits 100 Million Views

SEOUL, South Korea, April 4, 2022 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that its three-part 'NO OLED. NO GAME.' video series is under the global limelight, hitting more than 100 million views on the Internet. By introducing the outstand...

2022-04-05 09:00 1802

Vieworks to Make Its Debut at AACR Annual Meeting 2022 with VISQUE InVivo Series

ANYANG, South Korea, April 4, 2022 /PRNewswire/ -- Vieworks will be showcasing its optical in vivo imaging systems at AACR Annual Meeting (April 10-13, booth 2308). VISQUE InVivo Art is Vieworks' premium preclinical optical imaging system for high-sensitivity fluorescent & bioluminescent imaging ...

2022-04-04 21:00 1791

NEW ID Brings BABY SHARK TV Channel to Newly Launched Spanish-Language Streamer ViX

* BABY SHARK TV Channel is now available on ViX, the AVOD tier of TelevisaUnivision's new global Spanish-language streaming service. * The leading FAST distributor of Asian content, NEW ID expands its partnership with the global entertainment company behind Baby Shark, The Pinkfong Company, t...

2022-04-01 21:00 2362

DL E&C with differentiated competitiveness has reached the global CCUS stage.

- First Korean engineering and construction company to enter global CCUS market - Concluded preliminary agreement and MOU with NeuRizer Ltd and Drivetrain in Australia - Targeting the global market with customized solutions that realize ESG vision SEOUL, South Korea, April 1, 2022 /PRNewswire/ -- ...

2022-04-01 21:00 2715

Korea Ginseng Corp. Launches KORESELECT Line in the U.S. Market

- World's No.1 Ginseng Brand launched exclusive brand "Koreselect" for the U.S. - Lee Min-ho, Global Embassador of KGC, plays the role in Pachinko on Apple TV+ SEOUL, South Korea and NEW YORK, April 1, 2022 /PRNewswire/ -- Korea Ginseng Corporation (KGC), the world's number one ginseng brand, offi...

2022-04-01 14:45 1806

Smilegate Entertainment Celebrates CFS Grand Finals' 10th event

- CROSSFIRE Franchise Reaches 80 Countries Globally, 670 Million Total Registered Users and 8 Million Concurrent Players Worldwide with a Total of 1 Billion Cumulative in PC and mobile platforms SEOUL, South Korea, March 31, 2022 /PRNewswire/ -- Smilegate Entertainment

2022-03-31 22:00 1585

Aceemzyme Co., Ltd., challenging to new drug of brain diseases with recombinase-based ginsenoside Rh2 (s) mass production technology…

- Under development of ginsenoside Rh2(s) mass production technology… - "Enhanced production of ginsenoside Rh2(S) from PPD-type major ginsenosides using BglSk cloned fromSaccharibacillus kuerlensis together with two glycosidase in series" SOUTH KOREA, Seoul, March 31, 2022 /PRNewswire/ -- Ginse...

2022-03-31 21:00 893

SK Lubricants Investment in GRC Accelerates "Carbon to Green" Strategy

* SK Lubricants made an equity investment of $25 million in GRC, an American data center liquid immersion cooling solutions provider. - A signing ceremony for the investment, attended by CEOs of both companies, was held onMarch 29th, 2022 in SK Lubricants Americas Headquarters in Houston. - - S...

2022-03-30 10:34 1414

­­­­StradVision and ZF Partner to Accelerate The Future of Automated Driving Perception Technology

* Partnership strengthens ZF's global ecosystem for automated driving Level 3 and Level 4 systems * Perception software enables features/functions to meet regulatory safety standards and automated driving needs * Perception suitable across a range of mobility applications SEOUL, South Korea...

2022-03-29 22:00 1772

Samsung Biologics holds 11th Annual General Meeting of Shareholders

INCHEON, South Korea, March 28, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), hosted its 11th Annual General Meeting of Shareholders (AGM)today. Five matters were presented and approved unanimously at this ...

2022-03-29 09:42 1779

d'Alba Premium Vegan Brand, White truffle first spray serum has exceeded 90,000 reviews

SEOUL, South Korea, March 28, 2022 /PRNewswire/ -- The white truffle first spray serum, the main product of premium vegan brand d'Alba, surpassed 10 million global cumulative sales in January this year. Despite the difficult market due toCOVID-19 last year, the solid brand power in the domestic m...

2022-03-28 21:00 1668
1 ... 52535455565758 ... 100